Copernicus Capital Management, LLC 13F Holdings · last filed Q3 2021
Copernicus Capital Management, LLC reported 13 securities worth $8.26M in its SEC 13F filing for Q3 2021 (period ended 2021-09-30). Top holdings: PFE (15.61%), TMO (13.83%), TDOC (10.75%). Among its top 25 positions this quarter: 10 new, 2 added, 1 trimmed, 8 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PFE | PFIZER INC | $1.3M | 15.61% | 30,000 | New |
| 2 | TMO | THERMO FISHER SCIENTIFIC INC | $1.1M | 13.83% | 2,000 | New |
| 3 | TDOC | TELADOC HEALTH INC | $888,000 | 10.75% | 7,000 | New |
| 4 | BMRN | BIOMARIN PHARMACEUTICAL INC | $850,000 | 10.29% | 11,000 | New |
| 5 | JNJ | JOHNSON & JOHNSON | $808,000 | 9.78% | 5,000 | New |
| 6 | FATE | FATE THERAPEUTICS INC | $711,000 | 8.60% | 12,000 | Added |
| 7 | HZNP | HORIZON THERAPEUTICS PUB L | $657,000 | 7.95% | 6,000 | Added |
| 8 | RCUS | ARCUS BIOSCIENCES INC | $593,000 | 7.18% | 17,000 | Trimmed |
| 9 | ALLO | ALLOGENE THERAPEUTICS INC | $386,000 | 4.67% | 15,000 | New |
| 10 | MDT | MEDTRONIC PLC | $376,000 | 4.55% | 3,000 | New |
| 11 | PRQR | PROQR THRAPEUTICS N V | $335,000 | 4.05% | 40,000 | New |
| 12 | IMTX | IMMATICS N.V | $130,000 | 1.57% | 10,000 | New |
| 13 | FOLD | AMICUS THERAPEUTICS INC | $96,000 | 1.16% | 10,000 | New |
| 14 | ACCD | ACCOLADE INC | $0 | 0.00% | 0 | Exited |
| 15 | ATRA | ATARA BIOTHERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 16 | GRTS | GRITSTONE BIO INC | $0 | 0.00% | 0 | Exited |
| 17 | JAZZ | JAZZ PHARMACEUTICALS PLC | $0 | 0.00% | 0 | Exited |
| 18 | SKIN | THE BEAUTY HEALTH COMPANY | $0 | 0.00% | 0 | Exited |
| 19 | TCRR | TCR2 THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 20 | VRTX | VERTEX PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
| 21 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2021-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR